BioSpace News Archive

Despite the importance of calibration, many people don’t understand what it is and why it is necessary.

The updated data will be presented at the 2017 Society for Immunotherapy of Cancer Annual Meeting.

As of September 30, 2017, GlycoMimetics had cash and cash equivalents of $112.9 million as compared to $40.0 million as of December 31, 2016.

Jaguar Health announced today that it has signed a non-binding term sheet to issue to Iliad Research and Trading, L.P. (the “Investor”) a secured convertible promissory note (the “Note”) in the aggregate principal amount of $1,375,000 for an aggregate purchase price of $1,100,000.

Backed by Amgen Ventures, Fortuna Fix secured $25M in funding to push its autologous stem cell treatments for Parkinson’s disease and spinal cord injuries into the clinic.

[08-November-2017] INCLINE VILLAGE, Nev., Nov. 8, 2017 /PRNewswire/ -- PDL BioPharma, Inc. (NASDAQ: PDLI) reiterated that its proposal to acquire Neos Therapeutics, Inc. (NASDAQ: NEOS) for $10.25 per share in cash will expire today at market close. PDL originally made public its proposal to acquire Neos on October 26, 2017 at a premium of approximately 40 percent to the pre-proposal closin

Asuragen will host a corporate workshop and present three posters at the 2017 Association for Molecular Pathology (AMP) Conference November 15-18 in Salt Lake City.

ATR-101 was well-tolerated at all dose levels.

GraviFeed and Guardian Warmer have both received a 2017 Innovative Technology designation from Vizient, the largest member-driven health care performance improvement company in the country.

Tepha announced today recent developments and R & D initiatives in the field of regenerative medicine scaffolds for the repair or replacement of compromised human tissue.